THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS
The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH and much more…
Register your interest for the 2024 event to get first access to the agenda!
REGISTER»
Brand New Session Themes for 2023:
- Preclinical Development of Antibody Drugs: From Discovery to IND
- The Promise and the Challenges of Machine Learning and AI In Antibody Discovery
- Antibody Discovery, Selection and Engineering
- Novel Bispecifics, Multi-specifics and Therapeutic Combinations
- Antibody Therapies in Tumor Microenvironment
- Protein-Based Degraders for Therapeutic Development
Brand New Session Themes for 2023:
- Harnessing Antibodies for Autoimmunity and Inflammation
- Immune Cell Engager Antibody Technologies
- Engineering Antibody Immune Agonists
- Antibody Therapy for Neurodegenerative Diseases
- Antibody-Based Cell Therapies
- Antibody-based Drugs: Clinical Translation and Lessons Learned
3 Unmissable Add-On Options for 2023:
Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference.
Options include:
- Pre-Conference Half-Day Workshop A (PM): Pre-clinical Development of Antibody Drugs: From Discovery to IND
- Pre-Conference Half-Day Workshop B (PM): Artificial Intelligence and Machine Learning in Antibody Discovery
- Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering
